Related Experiment Video
Updated: Jun 26, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Problem-oriented drug information: physicians' expectations and impact on clinical practice.
1Department of Biochemistry, Pharmacology and Genetics, Odense University Hospital, Odense, Denmark. uhedegaard@health.sdu.dk
European Journal of Clinical Pharmacology
|January 13, 2009
Summary
Problem-oriented drug information (POD) services provide valuable, evidence-based answers that impact clinical practice. Physicians highly value POD, using it for patient care and disseminating information, overcoming barriers to evidence-based medicine.
Area of Science:
- Medical Informatics
- Clinical Pharmacy
- Evidence-Based Medicine
Background:
- Problem-oriented drug information (POD) services deliver evidence-based answers to clinical queries from healthcare professionals.
- Physicians often face challenges in accessing and applying up-to-date drug information.
Purpose of the Study:
- To evaluate user satisfaction and clinical impact of POD services.
- To identify predictors of POD utilization among physicians.
- To understand physicians' information-seeking behaviors before using POD.
Main Methods:
- A questionnaire-based evaluation was conducted.
- Data were collected from physicians receiving POD answers between April 2006 and March 2007.
- Response rate was 93% (183 out of 197 questionnaires).
Main Results:
- POD information was highly valued, with 90% of answers impacting clinical practice.
- 74% of answers were intended for broader use (future patients or colleagues).
- Physicians used POD to overcome barriers like lack of time and search skills; 78% sought evidence-based information.
Conclusions:
- POD is a valuable resource for physicians seeking evidence-based drug information.
- POD significantly impacts clinical practice and is utilized for both immediate patient care and future knowledge dissemination.
- Differences in POD usage exist between general practitioners and secondary-care physicians, with GPs focusing on patient information and secondary-care physicians on dissemination.
Related Concept Videos
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...